Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00458_DB01026_nanopub.RAsldTacG_M4HIpTD26PkH6FKGii_F1rMpsp32mcprono#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00458_DB01026 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00458_DB01026 label "DDI between Imipramine and Ketoconazole - Ketoconazole, a moderate CYP2D6 inhibitor, may increase the serum concentration of imipramine by increasing its metabolism. Monitor for changes in the therapeutic and adverse effects of imipramine if ketoconazole is initiated, discontinued or dose changed. [drugbank_resource:DB00458_DB01026]" assertion.
- drugbank_resource:DB00458_DB01026 identifier "drugbank_resource:DB00458_DB01026" assertion.
- drugbank_resource:DB00458_DB01026 title "DDI between Imipramine and Ketoconazole - Ketoconazole, a moderate CYP2D6 inhibitor, may increase the serum concentration of imipramine by increasing its metabolism. Monitor for changes in the therapeutic and adverse effects of imipramine if ketoconazole is initiated, discontinued or dose changed." assertion.
- drugbank:DB01026 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00458_DB01026 assertion.
- drugbank:DB00458 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00458_DB01026 assertion.